NCT02554383View on ClinicalTrials.gov

Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?

PHASE3CompletedINTERVENTIONAL
Enrollment

515

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2022

Study Completion Date

March 9, 2023

Conditions
SinusitisRespiratory Tract Infections
Interventions
DRUG

Amoxicillin-clavulanate

Amoxicillin-clavulanate (90/6.4 mg/kg/d in 2 divided dosed for 10 days)

DRUG

Placebo

placebo made to match the study antibiotic given twice a day orally for 10 days

Trial Locations (6)

15224

UPMC Children's Hospital of Pittsburgh, Pittsburgh

19104

The Children's Hospital of Philadelphia, Philadelphia

26501

WVU Medicine Pediatric and Adolescent Group Practice, Morgantown

40004

Kentucky Pediatric/Adult Research, Bardstown

53792

American Family Children's Hospital, Madison

97030

Cyn3rgy Research, Gresham

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Nader Shaikh

OTHER

NCT02554383 - Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit? | Biotech Hunter | Biotech Hunter